TANDEM DIABETES CARE INC
Company Stats
- Market Cap
- $1.1B
- as of Sep 30, 2026
- Shares Outstanding
- 69.6M
- Free Float
- 93.1%
Income Statement
- Revenue
- $1.0B
- Operating Income
- -$187.3M
- Net Income
- -$204.7M
- EBITDA
- -$169.6M
- Revenue Growth, 3Y
- 8.2%
- FCF Margin, 3Y Avg
- -3.4%
- FCF Margin, Worst Year
- -7.8%
Cash Flow
- Free Cash Flow
- -$29.7M
- FCF Yield
- -2.6%
- Owner FCF Yield
- -10.8%
Balance Sheet
- Cash & Equivalents
- $90.6M
Returns & Capital
- Buyback Yield, 3Y Avg
- 0.9%
- SBC, 3Y Avg
- $93.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.0B | -$29.7M | -2.9% |
| FY2024 | $940.2M | $5.0M | 0.5% |
| FY2023 | $747.7M | -$58.6M | -7.8% |
| FY2022 | $801.2M | $16.4M | 2.0% |
| FY2021 | $702.8M | $97.2M | 13.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back